 |
| CrossRef Text and Data Mining |
| Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining. |
| Combined biomarker for prediction of response to an immune checkpoint inhibitor in metastatic gastric cancer |
| You Jeong Heo, So Young Kang, Seung Tae Kim, Won Ki Kang, Jeeyun Lee, Kyoung-Mee Kim |
|
Precis Future Med. 2019;3(4):165-175. Published online December 11, 2019 DOI: https://doi.org/10.23838/pfm.2019.00079 |
|
Combined biomarker for prediction of response to an immune checkpoint inhibitor in metastatic gastric cancer Precision and Future Medicine. 2019;3(4):165-175  Modelling of Immune Checkpoint Network Explains Synergistic Effects of Combined Immune Checkpoint Inhibitor Therapy and the Impact of Cytokines in Patient Response Cancers. 2020;12(12):3600 Polyfunctionality Correlates with In Vivo Response to Immune Checkpoint Inhibitor Therapies Genetic Engineering & Biotechnology News. 2019;39(10):18-19 Perspectives: Neutrophil-to-lymphocyte Ratio as a Potential Biomarker in Immune Checkpoint Inhibitor for Non–Small-Cell Lung Cancer Clinical Lung Cancer. 2019;20(3):143-147 Sarcomas: Immune biomarker expression and checkpoint inhibitor trials Cancer Treatment Reviews. 2020;91:102115 Vitiligo after immune checkpoint inhibitor therapy in a woman with metastatic melanoma Journal of Cancer Research and Practice. 2018;5(4):161-164 Immune Checkpoint Blockade and Gastric Cancer Personalized Management of Gastric Cancer. 2017;115-130 Possible Biomarker for immune checkpoint inhibitor Annals of Oncology. 2017;28:ix20 Response of Metastatic Chordoma to the Immune Checkpoint Inhibitor Pembrolizumab: A Case Report Frontiers in Oncology. 2020;10: Is smoking history the truly best biomarker for immune checkpoint inhibitor treatment in advanced non-small cell lung cancer? ESMO Open. 2018;3(5):e000421 |
